Growth Metrics

Claritev (CTEV) Non-Current Deffered Revenue (2020)

Claritev's quarterly Non-Current Deffered Revenue came in at $38.5 million in Q3 2020, little changed quarter-over-quarter from $38.5 million in Q2 2020.

Claritev has reported Non-Current Deffered Revenue for 1 years, with the latest figure at $38.5 million in Q3 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn -
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 4.57 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn -
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn -
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn 400,000.00
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 5.16 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn 10.14 Mn
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn -
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn 63.07 Mn
10 Claritev 456.62 Mn 428.62 Mn 175.60 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2020 38.50 Mn
Jun 30, 2020 38.50 Mn
Mar 31, 2020 38.50 Mn